Skip to main content

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Investor Securities Class Action Lawsuit 06/06/2022

  • If you purchased a significant amount of shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) between May 28, 2021 and May 24, 2022, and / or if you purchased any NASDAQ: VRCA shares prior to May 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: VRCA investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 12, 2023 - An amended complaint was filed. June 6, 2022 - An investor in shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by Verrica Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements made between May...



You must register (for free) or login to view the entire case.